Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

78-84

06-07-2018

https://doi.org/10.4081/reumatismo.2018.1011

2492

PDF: 1307
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2633

PDF: 1361
Successful treatment of refractory adult onset Still’s disease with rituximab

N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

159-162

16-12-2016

https://doi.org/10.4081/reumatismo.2016.888

2422

PDF: 1178
Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

A. Lo Gullo, G. Mandraffino, C.O. Aragona, A. Molica Colella, A. Saitta, E. Imbalzano

184-188

21-12-2017

https://doi.org/10.4081/reumatismo.2017.1013

1462

PDF: 795
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2546

PDF: 1210
Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers

E. Catarsi, M. Doveri, A. Tavoni

79-81

27-05-2013

https://doi.org/10.4081/reumatismo.2013.79

3118

PDF: 854
Diffuse alveolar hemorrhage as a manifestation of Behçet disease

V. Grosso, E. Boveri, L. Bogliolo, C. Montecucco, R. Caporali

138-141

24-07-2013

https://doi.org/10.4081/reumatismo.2013.138

2647

PDF: 874
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

07-04-2025

https://doi.org/10.4081/reumatismo.2025.1817

1331

PDF: 386

SUPPLEMENTARY MATERIAL: 239
Treatment of hyperuricemia, gout and other crystalline arthritidies

F. Lioté

276-283

https://doi.org/10.4081/reumatismo.2011.276

1155

PDF: 1028
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2300

PDF: 1548
Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

46-50

https://doi.org/10.4081/reumatismo.2010.46

1085

PDF: 1306
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

G. Andrisani, E. Gremese, L. Guidi, A. Papa, M. Marzo, C. Felice, D. Pugliese, A. Armuzzi

75-78

27-05-2013

https://doi.org/10.4081/reumatismo.2013.75

2960

PDF: 889
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

50-56

https://doi.org/10.4081/reumatismo.2007.50

1127

PDF: 756
Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab

Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare

59-61

https://doi.org/10.4081/reumatismo.2006.59

894

PDF: 881
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients

Dilia Giuggioli, Rocco Magistro, Michele Colaci, Umberto Franciosi, Andrea Caruso, Clodoveo Ferri

26-30

https://doi.org/10.4081/reumatismo.2006.26

964

PDF: 1108
The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern

C. Iannone, M.R. Pellico, C. Campochiaro, L. Tescaro, M. Zompatori, A. Caminati, S. Harari, R. Caporali

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1611

1316

PDF: 552
Carpal tunnel syndrome treatment

Rossella De Angelis, Fausto Salaffi, Emilio Filippucci, Walter Grassi

5-10

https://doi.org/10.4081/reumatismo.2006.5

1852

PDF: 3034
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1470

9299

PDF: 2046
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

290-295

https://doi.org/10.4081/reumatismo.2008.290

2056

PDF: 1058
The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases

I. Miniati, R. Saccardi, F. Pagliai, S. Guiducci, A. Bosi, S. Guidi, S. Urbani, A. Tyndall, M. Matucci Cerinic

277-282

https://doi.org/10.4081/reumatismo.2005.277

965

PDF: 1494
Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa

A.A. Akpabio, B.I. Otike-Odibi

115-119

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1274

1057

PDF: 633
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

244-261

https://doi.org/10.4081/reumatismo.2007.244

1288

PDF: 1105
The treatment of recurrent uveitis with TNFα inhibitors

P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

185-189

https://doi.org/10.4081/reumatismo.2004.185

1729

PDF: 2354
Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)

M.T. Riccardi, A. Chialà, F. Iannone, V. Grattagliano, M. Covelli, G. Lapadula

135-139

https://doi.org/10.4081/reumatismo.2007.135

1143

PDF: 735
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

28-10-2024

https://doi.org/10.4081/reumatismo.2024.1796

1524

PDF: 240
Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

Ana Martins, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito

11-11-2024

https://doi.org/10.4081/reumatismo.2024.1640

1412

PDF: 177

1 - 26 of 26 items

Search

Search Results

The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

Successful treatment of refractory adult onset Still’s disease with rituximab

Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

Intra-articular therapy with tumor necrosis factor-α antagonists: an update

Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers

Diffuse alveolar hemorrhage as a manifestation of Behçet disease

Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Treatment of hyperuricemia, gout and other crystalline arthritidies

Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab

The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients

The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern

Carpal tunnel syndrome treatment

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases

Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa

Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

The treatment of recurrent uveitis with TNFα inhibitors

Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)

Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

authors

reviewers

Categories

indexing

Keywords